UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 107

Sortiert nach

Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study

Annals of the rheumatic diseases, 2011-06, Vol.70 (6), p.1108-1110

2011

Volltextzugriff (PDF)

Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison

Arthritis research & therapy, 2019-06, Vol.21 (1), p.142-142, Article 142

2019

Volltextzugriff (PDF)

Open label trial of anakinra in active ankylosing spondylitis over 24 weeks

Annals of the rheumatic diseases, 2005-02, Vol.64 (2), p.296-298

2005

Volltextzugriff (PDF)

Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial

Annals of the rheumatic diseases, 2011-04, Vol.70 (4), p.590-596

2011

Volltextzugriff (PDF)

Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes

Annals of the rheumatic diseases, 2007-07, Vol.66 (7), p.910-915

2007

Volltextzugriff (PDF)

Efficacy of oral prednisolone in active ankylosing spondylitis: results of a double-blind, randomised, placebo-controlled short-term trial

Annals of the rheumatic diseases, 2014-01, Vol.73 (1), p.243-246

2014

Volltextzugriff (PDF)

No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial

Annals of the rheumatic diseases, 2007-03, Vol.66 (3), p.419-421

2007

Volltextzugriff (PDF)

Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-α antibody infliximab

Rheumatology (Oxford, England), 2007-09, Vol.46 (9), p.1450-1453

2007

Volltextzugriff (PDF)

Long‐Term Efficacy of Adalimumab After Drug Withdrawal and Retreatment in Patients With Active Non–Radiographically Evident Axial Spondyloarthritis Who Experience a Flare

Arthritis & rheumatology (Hoboken, N.J.), 2013-08, Vol.65 (8), p.2211-2213

2013

Volltextzugriff (PDF)

Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48

Annals of the rheumatic diseases, 2011-07, Vol.70 (7), p.1257-1263

2011

Volltextzugriff (PDF)

Six months open label trial of leflunomide in active ankylosing spondylitis

Annals of the rheumatic diseases, 2005-01, Vol.64 (1), p.124-126

2005

Volltextzugriff (PDF)

Health care and disease burden in persons with axial spondyloarthritis in Germany

Zeitschrift für Rheumatologie, 2019-11, Vol.78 (9), p.865-874

2019

Volltextzugriff (PDF)

Cost of illness in axial spondylarthritis for patients with and without tumor necrosis factor inhibitor treatment: results of a routine data analysis

Zeitschrift für Rheumatologie, 2020-02, Vol.79 (1), p.85-94

2020

Volltextzugriff (PDF)

THU0379 Clinical Disease Activity Measures Are Associated with Radiographic Spinal Progression in Early Axial Spondyloarthritis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.324-325

2016

Volltextzugriff (PDF)

Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab

Rheumatology (Oxford, England), 2005-12, Vol.44 (12), p.1525-1530

2005

Volltextzugriff (PDF)

Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis

Rheumatology (Oxford, England), 2005-03, Vol.44 (3), p.342-348

2005

Volltextzugriff (PDF)

Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial

Annals of the rheumatic diseases, 2006-09, Vol.65 (9), p.1147-1153

2006

Volltextzugriff (PDF)

Enthesitis in the context of spondyloarthritides

Zeitschrift für Rheumatologie, 2015-02, Vol.74 (1), p.39

2015

Volltextzugriff (PDF)

FRI0114 Reaching A Status of Low Disease Activity Spontaneously over Two Year Follow-Up in Active Patients with Non-Radiographic Axial Spondyloarthritis in Comparison to Ankylosing Spondylitis not Treated with TNF Blockers

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.422-423

2014

Volltextzugriff (PDF)

FRI0113 Persistently High Disease Activity According to the ASDAS is Associated with Accelerated Radiographic Spinal Progression in Patients with Axial Spondyloarthritis

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.422-422

2014

Volltextzugriff (PDF)

THU0071 Patients with Non-Radiographic Axial Spondyloarthritis and Ankylosing Spondylitis Demonstrate the Same Clinical Disease Course over Two Years: Results from the GESPIC Cohort

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.201-201

2014

Volltextzugriff (PDF)

SAT0422 Long-Term anti-TNF Treatment Is Associated with Reduction of Progression of Radiographic Changes in The Sacroiliac Joints in Patients with Non-Radiographic Axial SpA: Six-Year Results of The Esther Trial

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.823-824

2016

Volltextzugriff (PDF)

Use of methotrexate in patients with ankylosing spondylitis

Clinical and experimental rheumatology, 2010-09, Vol.28 (5 Suppl 61), p.S128

2010

Volltextzugriff (PDF)

THU0199 Functional Status Remains Stable Despite Continuous Radiographic Spinal Progression Over Ten Years in Patients with Ankylosing Spondylitis Receiving Anti-TNF Therapy

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.267-267

2015

Volltextzugriff (PDF)

Successful short term treatment of severe undifferentiated spondyloarthropathy with the anti-tumor necrosis factor-alpha monoclonal antibody infliximab

Journal of rheumatology, 2002-01, Vol.29 (1), p.118

2002

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(93)

Publikationsform

Artikel
(105)
Buchkapitel
(2)

Sprache

Englisch
(82)
Deutsch
(25)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Life Sciences & Biomedicine
(46)
Rheumatology
(45)
Humans
(43)
Female
(32)
Biological And Medical Sciences
(27)
Male
(27)
Adult
(26)
Spondylitis, Ankylosing - Drug Therapy
(25)
Medical Sciences
(24)
Antirheumatic Agents - Therapeutic Use
(23)
Treatment Outcome
(23)
Diseases Of The Osteoarticular System
(21)
Ankylosing Spondylitis
(20)
Middle Aged
(19)
Inflammatory Joint Diseases
(17)
Diseases Of The Spine
(15)
Pharmacology. Drug Treatments
(13)
Severity Of Illness Index
(13)
Tumor Necrosis Factor-Alpha - Antagonists & Inhibitors
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study

Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison

Open label trial of anakinra in active ankylosing spondylitis over 24 weeks

Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial

Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes

Efficacy of oral prednisolone in active ankylosing spondylitis: results of a double-blind, randomised, placebo-controlled short-term trial

No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial

Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-α antibody infliximab

Long‐Term Efficacy of Adalimumab After Drug Withdrawal and Retreatment in Patients With Active Non–Radiographically Evident Axial Spondyloarthritis Who Experience a Flare

Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48

Six months open label trial of leflunomide in active ankylosing spondylitis

Health care and disease burden in persons with axial spondyloarthritis in Germany

Cost of illness in axial spondylarthritis for patients with and without tumor necrosis factor inhibitor treatment: results of a routine data analysis

THU0379 Clinical Disease Activity Measures Are Associated with Radiographic Spinal Progression in Early Axial Spondyloarthritis

Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab

Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis

Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial

Enthesitis in the context of spondyloarthritides

FRI0114 Reaching A Status of Low Disease Activity Spontaneously over Two Year Follow-Up in Active Patients with Non-Radiographic Axial Spondyloarthritis in Comparison to Ankylosing Spondylitis not Treated with TNF Blockers

FRI0113 Persistently High Disease Activity According to the ASDAS is Associated with Accelerated Radiographic Spinal Progression in Patients with Axial Spondyloarthritis

THU0071 Patients with Non-Radiographic Axial Spondyloarthritis and Ankylosing Spondylitis Demonstrate the Same Clinical Disease Course over Two Years: Results from the GESPIC Cohort

SAT0422 Long-Term anti-TNF Treatment Is Associated with Reduction of Progression of Radiographic Changes in The Sacroiliac Joints in Patients with Non-Radiographic Axial SpA: Six-Year Results of The Esther Trial

Use of methotrexate in patients with ankylosing spondylitis

THU0199 Functional Status Remains Stable Despite Continuous Radiographic Spinal Progression Over Ten Years in Patients with Ankylosing Spondylitis Receiving Anti-TNF Therapy

Successful short term treatment of severe undifferentiated spondyloarthropathy with the anti-tumor necrosis factor-alpha monoclonal antibody infliximab

Suchergebnisse filtern